The standards documents have been approved by the BSPED and reflect the Society's views on best practice for the average patient. Each patient must be considered as an individual in the context of their condition and other medication, and whilst every effort has been made to ensure the factual accuracy of the contents no liability can be accepted for any litigation, claims or complaints arising from the use of the standards, which is solely at the discretion of the reader.
UK standards for Paediatric Endocrinology
The UK standards for Paediatric Endocrinology were initially published in 2019 and have been updated in 2024 by the BSPED. They are endorsed by the Royal College of Paediatrics and Child Health. The standards apply to all children and young people aged 0-18 years with an endocrine condition. The aims of the standards are to reduce variability in care and to ensure that equitable services providing high quality, safe and effective care are available to all children and families across the UK. The standards are intended for healthcare professionals and for service commissioners to plan, deliver and quality assure paediatric endocrine services. Review date: January 2029
BSPED Endorsed Standards
| Creation Date | Revision Date | |
|
|
November 2022 | November 2026 |
|
|
September 2022 | September 2025 |
| Clinical Standards For GH Treatment Of Growth Disorders Excluding GHD 19122023
|
December 2023 | December 2026 |
|
|
August 2022 | August 2027 |
 Clinical Standards for Management of an Infant or Adolescent presenting with a suspected differences of sex development (DSD) |
Nov 2017 | 2022 (Following review of Paediatric Endocrinology Specifications for DSD) |
| Paediatric Endocrine Conditions and Suggested Types and Frequency of Clinical Reviews during and after the COVID-19 crises |
March 2022 | March 2025 |